Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients

NCT00174824 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1024

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin glargine

Sponsor

Sanofi